Should you buy Rio Tinto Limited?

Despite a solid third operations report released yesterday, which includes the likelihood of increased dividends, Rio Tinto Limited (ASX:RIO) continues to fall.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares in Rio Tinto Limited (ASX: RIO) have once again fallen today, down nearly 2% in afternoon trade. Since the beginning of 2014 it's down 12%.

Thanks to a falling iron ore price – down around 40% in 2014 – Rio and its rival miners have had a year they'd rather forget.

Whilst Rio has been able to avoid most of the selloff, pure play iron ore miners, Fortescue Metals Group Limited (ASX: FMG) and Atlas Iron Limited (ASX: AGO) are down 40% and 67%, respectively.

As Australia's largest iron ore miner, Rio's estimated breakeven cost is just $US43 per tonne. This compares with the more diversified BHP Billiton Limited's (ASX: BHP) breakeven price of around $US45 per tonne.

Fortescue, the world's fourth largest producer, has an estimated breakeven price above $US70 per tonne. However, its mines produce a lower quality ore and attract a discounted price to that of its two larger rivals. Currently iron ore sells for around $US82 per tonne.

But low cost of production isn't the only reason Rio shares have been shielded from the selloff. Its operations are diversified across commodities such as copper, coal and aluminium. Which gives it an edge over its rivals.

However, with 90% of profits derived from iron ore last financial year, it's no wonder the falling spot price has had such a profound effect on the $104 billion miner.

Buy, Hold, or Sell

Despite a bumper third quarter operations report (which included hints of a larger dividend payout) released yesterday and a seemingly cheap share price, Rio appears likely to remain a highly volatile investment for the foreseeable future. As such, risk-averse investors would be advised to keep their distance, for now.

Motley Fool Contributor Owen Raszkiewicz is long Dec 2017 $47 Warrants in Rio Tinto Limited. 

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »